Case number 1:23-cv-02942
JANSSEN PHARMACEUTICALS, INC. et al v. HIKMA PHARMACEUTICALS USA INC. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 30, 2023 | 9 | MOTION for Leave to Appear Pro Hac Vice by JANSSEN PHARMACEUTICA NV, JANSSEN PHARMACEUTICALS, INC.. (Attachments: # 1 Declaration of Keith J. Miller, Esq., # 2 Declaration of Andrew Cohen, Esq., # 3 Declaration of Aron Fisher, Esq., # 4 Declaration of Barbara Mullin, Esq., # 5 Declaration of Jay Cho, Esq., # 6 Declaration of Lachlan Campbell-Verduyn, Esq., # 7 Declaration of Peter Vogel, Esq., # 8 Declaration of Shelli Gimelstein, Esq., # 9 Text of Proposed Order)(MILLER, KEITH) (Entered: 06/30/2023) (0) |
| Jun 15, 2023 | 8 | STIPULATION AND ORDER Dismissing without prejudice defendants HIKMA PHARMACEUTICALS PLC and WEST-WARD COLUMBUS INC. and amending caption. The time for HIKMA PHARMACEUTICALS USA INC. to answer or otherwise respond to Plaintiffs' complaint is extended until 7/7/2023. Signed by Judge Karen M. Williams on 6/15/2023. (jab) (Entered: 06/15/2023) (4) |
| Jun 14, 2023 | 7 | Letter from Michael J. Gesualdo, Esq. to Hon. Karen M. Williams, U.S.D.J. Enclosing Proposed Stipulation and Order. (Attachments: # 1 Text of Proposed Order)(GESUALDO, MICHAEL) (Entered: 06/14/2023) (0) |
| Jun 13, 2023 | 6 | NOTICE of Appearance by JAMES S. RICHTER on behalf of HIKMA PHARMACEUTICALS USA INC. (RICHTER, JAMES) (Entered: 06/13/2023) (1) |
| Jun 6, 2023 | 5 | SUMMONS Returned Executed by JANSSEN PHARMACEUTICALS, INC., JANSSEN PHARMACEUTICA NV. HIKMA PHARMACEUTICALS USA INC. served on 6/2/2023, answer due 6/23/2023. (MILLER, KEITH) (Entered: 06/06/2023) (1) |
| Jun 1, 2023 | 3 | SUMMONS ISSUED as to HIKMA PHARMACEUTICALS PLC, HIKMA PHARMACEUTICALS USA INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (ssp, ) (Entered: 06/01/2023) (2) |
| Jun 1, 2023 | 4 | AO120 Patent/Trademark Form filed. (ssp, ) (Entered: 06/01/2023) (1) |
| May 31, 2023 | 2 | Corporate Disclosure Statement by JANSSEN PHARMACEUTICA NV, JANSSEN PHARMACEUTICALS, INC. identifying Johnson & Johnson as Corporate Parent.. (MILLER, KEITH) (Entered: 05/31/2023) (2) |
| May 30, 2023 | 1 | Complaint* (1) |
